Wall Street is positive on Arena Pharmaceuticals, Inc. (ARNA). On average, analysts give ARNA a Buy rating. The average price target is $96.375, which means analysts expect the stock to add by 5.81% over the next twelve months. That average ranking earns ARNA an Analyst Rating of 18, which is better than 18% of stocks based on data compiled by InvestorsObserver.
Do Analysts Expect Arena Pharmaceuticals, Inc. (ARNA) Stock to Rise After It Has Risen 0.19% in a Month?
Wall Street analysts are rating ARNA a Buy today. Find out what this means to you and get the rest of the rankings on ARNA!